Regulation of Fas receptor/Fas-asssociated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain

British Journal of Pharmacology

Volumn 160, Issue 3, 2010, Pages 643-656

  Alvaro Bartolome M ^a,b   Esteban, S ^a,b   Garcia Gutierrez M S ^b,c   Manzanares, J ^b,c   Valverde, O ^b,d   Garcia Sevilla J A ^a,b  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b RETICS Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares Oftared   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Akt PEA 15; Apoptosis; CB 1 and CB 2 receptor deficient mice; FADD adaptor; Fas receptor; JWH133; MAPKs; Mouse brain; WIN55,212 2

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN KINASE B; RIMONABANT; STRESS ACTIVATED PROTEIN KINASE; 1,1-DIMETHYLBUTYL-1-DEOXY-DELTA(9)-THC; APOPTOSIS REGULATORY PROTEIN; BENZOXAZINE DERIVATIVE; CANNABINOID; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL FRACTIONATION; CONTROLLED STUDY; GENOTYPE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; AGONISTS; ANIMAL; BRAIN; DOWN REGULATION; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM;

ANIMALS; ANTIGENS, CD95; APOPTOSIS REGULATORY PROTEINS; BENZOXAZINES; BRAIN; CANNABINOIDS; CELL DEATH; DOWN-REGULATION; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; MALE; MICE; MICE, KNOCKOUT; MORPHOLINES; NAPHTHALENES; POLY(ADP-RIBOSE) POLYMERASES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77952601644     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00710.x     Document Type: Article

References (54)

1. 1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J Biol Chem 282 : 23892 23898.
2. Alappat EC, Feig C, Boyerinas B, Volkland J, Samuels M, Murmann AE et al 2005). Phosphorylation of FADD at serine 194 by CKIα regulates its nonapoptotic activities. Mol Cell 19 : 321 332.
3. Alexander SPH, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
4. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK, Peter ME (2002). Molecular ordering of the initial signaling events of CD95. Mol Cell Biol 22 : 207 220.
5. 1 receptor-deficient mice. Eur Neuropsychopharmacol 18 (Suppl. 4 S230 S231.
6. Barna I, Till I, Haller J (2009). Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: compound-specific and area-specific distribution within the brain. Eur Neuropsychopharmacol 19 : 533 541.
7. Boronat MA, García-Fuster MJ, García-Sevilla JA 2001). Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br J Pharmacol 134 : 1263 1270.
8. 2 receptor. Eur J Pharmacol 396 : 141 149.
9. Canals M, Milligan G (2008). Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed mu opioid receptors. J Biol Chem 283 : 11424 11434.
10. Chin C-L, Tovcimak AE, Hradil VP, Seifert TR, Hollingsworth PR, Chandran P et al 2008). Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. Br J Pharmacol 153 : 367 379.
11. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81 : 505 512.
12. Costa T, Herz A (1989). Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86 : 7321 7325.
13. Demuth DG, Molleman A (2006). Cannabinoid signalling. Life Sci 78 : 549 563.
14. 1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons. Br J Pharmacol 140 : 547 557.
15. 9-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex. Brain Res 1175 : 39 47.
16. Galluzzi L, Blomgren K, Kroemer G (2009). Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 10 : 481 494.
17. Galve-Roperh I, Aguado T, Palazuelos J, Guzmán M (2008). Mechanisms of control of neuron survival by the endocannabinoid system. Curr Pharm Des 14 : 2279 2288.
18. García-Fuster MJ, Miralles A, García-Sevilla JA (2007a). Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway. Neuropsychopharmacology 32 : 399 411.
19. García-Fuster MJ, Ferrer-Alcón M, Martín M, Kieffer BL, Maldonado R, García-Sevilla JA (2007b). Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: a Δ-opioid tone inhibits FADD. Eur Neuropsychopharmacol 17 : 366 374.
20. García-Fuster MJ, Ramos-Miguel A, Miralles A, García- Sevilla JA (2008a). Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: functional interactions with casein kinase Iα, Gαi proteins, and ERK1/2 signaling. Neuropharmacology 55 : 886 899.
21. García-Fuster MJ, Ramos-Miguel A, Rivero G, La Harpe R, Meana JJ, García-Sevilla JA (2008b). Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers. Neuroscience 157 : 105 119.
22. García-Fuster MJ, Clinton SM, Watson SJ, Akil H (2009). Effect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuse. Neuropsychopharmacology 34 : 1123 1134.
23. Gifford AN, Ashby CR Jr. (1996). Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 552122-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J Pharmacol Exp Ther 277 : 1431 1436.
24. Gong J-P, Onaivi ES, Ishiguro H, Liu Q-R, Tagliaferro PA, Brusco A et al 2006). Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071 : 10 23. (Pubitemid 43255471)
25. 9- tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. Drug Alcohol Depend 74 : 159 170.
26. Guzmán M, Sánchez C, Galve-Roperh I (2002). Cannabinoids and cell fate. Pharmacol Ther 95 : 175 184.
27. Herkenham M, Lynn AB, Johnson MR, Melvin LS, De Costa BR, Rice KC (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11 : 563 583.
28. 2 receptor ligands. Mini Rev Med Chem 5 : 641 649.
29. Katona I, Sperlágh B, Sík A, Käfalvi A, Vizi ES, Mackie K et al 1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurones. J Neurosci 19 : 4544 4558.
30. Kumar S (2007). Caspase function in programmed cell death. Cell Death Differ 14 : 32 43.
31. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F et al 1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 : 401 404.
32. Leterrier C, Bonnard D, Carrel D, Rossier J, Lenkei Z (2004). Constitutive endocytic cycle of the CB1 cannabinoid receptor. J Biol Chem 279 : 36013 36021.
33. Lossi L, Merighi A (2003). In vivo cellular and molecular mechanisms of neuronal apoptosis in the mammalian CNS. Prog Neurobiol 69 : 287 312.
34. Maccarrone M, Finazzi-Agró A (2003). The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ 10 : 946 955.
35. 1 cannabinoid receptor knockout mice of different ages. J Neurochem 78 : 339 348.
36. Moranta D, Esteban S, García-Sevilla JA (2007). Acute, chronic and withdrawal effects of the cannabinoid receptor agonist WIN55212-2 on the sequential activation of MAPK/Raf-MEK-ERK signaling in the rat cerebral frontal cortex: short-term regulation by intrinsic and extrinsic pathways. J Neurosci Res 85 : 656 667.
37. Narita M, Kuzumaki N, Miyatake M, Sato F, Wachi H, Seyama Y et al 2006). Role of Δ-opioid receptor function in neurogenesis and neuroprotection. J Neurochem 97 : 1494 1505.
38. Ozaita A, Puighermanal E, Maldonado R (2007). Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. J Neurochem 102 : 1105 1114.
39. 2 receptors. Pharmacol Ther 74 : 129 180.
40. 1 receptors. Life Sci 76 : 1307 1324.
41. L gene expression. J Neurosci Res 83 : 1058 1065.
42. Price DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernandez E et al 2009). WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Eur J Neurosci 29 : 2177 2186.
43. Putt KS, Beilman GJ, Hergenrother PJ (2005). Direct quantitation of poly(ADP-ribose) polymerase (PARP) activity as a means to distinguish necrotic and apoptotic death in cell and tissue samples. Chembiochem 6 : 53 55.
44. Ramos-Miguel A, García-Fuster MJ, Callado LF, La Harpe R, Meana JJ, García-Sevilla JA (2009). Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pathways involved in neuroplasticity. Neuroscience 161 : 23 38.
45. Ramos-Miguel A, Esteban S, García-Sevilla JA (2010). The time course of unconditioned morphine-induced psychomotor sensitization mirrors the phosphorylation of FADD and MEK/ERK in rat striatum: role of PEA-15 as a FADD-ERK binding partner in striatal plasticity. Eur Neuropsychopharmacol 20 : 49 64.
46. 1 receptor stimulation in specific brain regions differentially modulate anxiety-related behaviour. Neuropharmacology 54 : 151 160.
47. Scott FL, Stec B, Pop C, Dobaczewska MK, Lee JJ, Monosov E et al 2009). The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature 457 : 1019 1022.
48. 1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol 15 : 91 119.
49. Sulcova E, Mechoulam R, Fride E (1998). Biphasic effects of anandamide. Pharmacol Biochem Behav 59 : 347 352.
50. 1 receptor knockout mice. Eur J Neurosci 22 : 2106 2110.
51. Valjent E, Pagès C, Rogard M, Besson MJ, Maldonado R, Caboche J (2001). Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur J Neurosci 14 : 342 352.
52. 1 cannabinoid receptor knockout mice. Handb Exp Pharmacol 168 : 117 145.
53. Viscomi MT, Oddi S, Latini L, Pasquariello N, Florenzano F, Bernardi G et al 2009). Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci 29 : 4564 4570.
54. Zhang J, Zhang D, Hua Z (2004). FADD and its phosphorylation. IUBMB Life 56 : 395 401.